Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Assets Average (2021 - 2025)

Historic Assets Average for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to $27.2 million.

  • HCW Biologics' Assets Average rose 183.34% to $27.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.2 million, marking a year-over-year increase of 183.34%. This contributed to the annual value of $29.4 million for FY2024, which is 2200.21% down from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' Assets Average is $27.2 million, which was up 183.34% from $27.6 million recorded in Q2 2025.
  • Over the past 5 years, HCW Biologics' Assets Average peaked at $55.0 million during Q4 2021, and registered a low of $26.7 million during Q3 2024.
  • For the 5-year period, HCW Biologics' Assets Average averaged around $37.8 million, with its median value being $34.7 million (2021).
  • Per our database at Business Quant, HCW Biologics' Assets Average soared by 4222.72% in 2022 and then tumbled by 3475.88% in 2024.
  • Quarter analysis of 5 years shows HCW Biologics' Assets Average stood at $55.0 million in 2021, then dropped by 10.7% to $49.1 million in 2022, then tumbled by 34.67% to $32.1 million in 2023, then dropped by 11.44% to $28.4 million in 2024, then fell by 4.29% to $27.2 million in 2025.
  • Its Assets Average stands at $27.2 million for Q3 2025, versus $27.6 million for Q2 2025 and $28.3 million for Q1 2025.